Nicholas Company’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Nicholas Company’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-290,890	Closed	-$7.09M	–	223
2017 Q4	$7.09M	Buy	290,890 +12,500	+4%	+$240K	0.15%	133
2017 Q3	$5.14M	Buy	278,390 +30,705	+12%	+$532K	0.11%	171
2017 Q2	$4.1M	Buy	247,685 +226,190	+1,052%	+$3.15M	0.09%	187
2017 Q1	$296K	Buy	+21,495	New	+$345K	0.01%	204

Nicholas Company's ENTL Position: Q1 2018 in Review

Nicholas Company sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 290,890 shares — an estimated $7.09M sold.

Nicholas Company first reported a position in ENTL in Q1 2017 and held it in 4 quarters. The position peaked at $7.09M in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

Nicholas Company reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Nicholas Company sold 290,890 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $7.09M.
Nicholas Company first reported a position in Entellus Medical, Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Nicholas Company's Entellus Medical, Inc. Common Stock position peaked at $7.09M in Q4 2017.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Nicholas Company's 13F filing for Q1 2018, filed 14 May 2018.